These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3689364)

  • 1. Inhibition of protein kinase C activity by the Leishmania donovani lipophosphoglycan.
    McNeely TB; Turco SJ
    Biochem Biophys Res Commun; 1987 Oct; 148(2):653-7. PubMed ID: 3689364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transbilayer inhibition of protein kinase C by the lipophosphoglycan from Leishmania donovani.
    Giorgione JR; Turco SJ; Epand RM
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11634-9. PubMed ID: 8876188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmania lipophosphoglycan activates the transcription factor activating protein 1 in J774A.1 macrophages through the extracellular signal-related kinase (ERK) and p38 mitogen-activated protein kinase.
    Balaraman S; Singh VK; Tewary P; Madhubala R
    Mol Biochem Parasitol; 2005 Jan; 139(1):117-27. PubMed ID: 15610826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the major carbohydrate fragment of the Leishmania donovani lipophosphoglycan.
    Turco SJ; Hull SR; Orlandi PA; Shepherd SD; Homans SW; Dwek RA; Rademacher TW
    Biochemistry; 1987 Sep; 26(19):6233-8. PubMed ID: 3689770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitory effects on protein kinase C activity by lipophosphoglycan fragments and glycosylphosphatidylinositol antigens of the protozoan parasite Leishmania.
    McNeely TB; Rosen G; Londner MV; Turco SJ
    Biochem J; 1989 Apr; 259(2):601-4. PubMed ID: 2524191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proposal for a function of the Leishmania donovani lipophosphoglycan.
    Turco SJ
    Biochem Soc Trans; 1988 Jun; 16(3):259-61. PubMed ID: 3181610
    [No Abstract]   [Full Text] [Related]  

  • 7. Requirement of lipophosphoglycan for intracellular survival of Leishmania donovani within human monocytes.
    McNeely TB; Turco SJ
    J Immunol; 1990 Apr; 144(7):2745-50. PubMed ID: 2319134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of phagolysosome biogenesis by the lipophosphoglycan of Leishmania.
    Lodge R; Descoteaux A
    Clin Immunol; 2005 Mar; 114(3):256-65. PubMed ID: 15721836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of macrophage protein kinase C-mediated protein phosphorylation by Leishmania donovani lipophosphoglycan.
    Descoteaux A; Matlashewski G; Turco SJ
    J Immunol; 1992 Nov; 149(9):3008-15. PubMed ID: 1383336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell surface lipophosphoglycan of Leishmania donovani.
    King DL; Chang YD; Turco SJ
    Mol Biochem Parasitol; 1987 May; 24(1):47-53. PubMed ID: 3614272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of Leishmania donovani infection levels by selective impairment of macrophage signal transduction.
    Moore KJ; Labrecque S; Matlashewski G
    J Immunol; 1993 May; 150(10):4457-65. PubMed ID: 8482844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Leishmania donovani variant clones using anti-lipophosphoglycan monoclonal antibodies.
    McNeely TB; Tolson DL; Pearson TW; Turco SJ
    Glycobiology; 1990 Sep; 1(1):63-9. PubMed ID: 2136382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmania donovani promastigotes evade the activation of mitogen-activated protein kinases p38, c-Jun N-terminal kinase, and extracellular signal-regulated kinase-1/2 during infection of naive macrophages.
    Privé C; Descoteaux A
    Eur J Immunol; 2000 Aug; 30(8):2235-44. PubMed ID: 10940915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-species and stage-specific polymorphisms in lipophosphoglycan structure control Leishmania donovani-sand fly interactions.
    Mahoney AB; Sacks DL; Saraiva E; Modi G; Turco SJ
    Biochemistry; 1999 Aug; 38(31):9813-23. PubMed ID: 10433687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory effect of mitoxantrone on activity of protein kinase C and growth of HL60 cells.
    Takeuchi N; Nakamura T; Takeuchi F; Hashimoto E; Yamamura H
    J Biochem; 1992 Dec; 112(6):762-7. PubMed ID: 1295884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmania donovani lipophosphoglycan selectively inhibits signal transduction in macrophages.
    Descoteaux A; Turco SJ; Sacks DL; Matlashewski G
    J Immunol; 1991 Apr; 146(8):2747-53. PubMed ID: 1707920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of the lipid moiety of the Leishmania donovani lipophosphoglycan.
    Orlandi PA; Turco SJ
    J Biol Chem; 1987 Jul; 262(21):10384-91. PubMed ID: 3611065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphorylation of type II (beta) protein kinase C by casein kinase II.
    Tominaga M; Kitagawa Y; Tanaka S; Kishimoto A
    J Biochem; 1991 Oct; 110(4):655-60. PubMed ID: 1778990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the glucosyltransferases that assemble the side chains of the Indian Leishmania donovani lipophosphoglycan.
    Mahoney AB; Turco SJ
    Arch Biochem Biophys; 1999 Dec; 372(2):367-74. PubMed ID: 10600177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of protein kinase C by semisynthetic phospholipid plasmanyl-(N-acyl)-ethanolamine, a nontoxic antitumor preparation.
    Mikhaevich IS; Gerasimova GK; Kára J
    Biochem Int; 1991 Jan; 23(2):215-20. PubMed ID: 1859429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.